Clinical Trial: Neoadjuvant Therapy with Anti-EGFR Antibody-Drug Conjugate Plus PD-1 Inhibitor for Locally Advanced Penile Squamous Cell Carcinoma (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Neoadjuvant Therapy with Anti-EGFR Antibody-Drug Conjugate Plus PD-1 Inhibitor for Locally Advanced Penile Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135851

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338640

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Neoadjuvant Therapy with Anti-EGFR Antibody-Drug Conjugate Plus PD-1 Inhibitor for Locally Advanced Penile Squamous Cell Carcinoma (China)